KPMA to oppose against big FTA deals on drug issues.

Published: 2007-03-09 07:00:00

Updated: 2007-03-09 07:00:00

The 8th KORUS FTA meeting was scheduled to hold on March 6, and the KPMA top executive groups met with the chief negotiators of the Ministry of Foreign Affairs and Trade, delivering the KPMA official position that any big deals at sacrifice of the pharmaceutical issues would kill the local drug ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK